𝔖 Bobbio Scriptorium
✦   LIBER   ✦

On the cost–effectiveness of PRAMs

✍ Scribed by Ferri Abolhassan; Jörg Keller; Wolfgang J. Paul


Publisher
Springer-Verlag
Year
1999
Tongue
English
Weight
146 KB
Volume
36
Category
Article
ISSN
0001-5903

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Affordability and cost-effectiveness: de
✍ P. Pedram Sendi; Andrew H. Briggs 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

## Abstract Much recent research interest has focused on handling uncertainty in cost‐effectiveness analysis and in particular the calculation of confidence intervals for incremental cost‐effectiveness ratios (ICERs). Problems of interpretation when ICERs are negative have led to two important and

Bayesian cost-effectiveness analysis wit
✍ Miguel A. Negrín; Francisco J. Vázquez-Polo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 1 views

Cost-effectiveness analysis (CEA) compares the costs and outcomes of two or more technologies. However, there is no consensus about which measure of effectiveness should be used in each analysis. Clinical researchers have to select an appropriate outcome for their purpose, and this choice can have d

The cost-effectiveness of home birth
✍ Rondi E Anderson; David A Anderson 📂 Article 📅 1999 🏛 Elsevier Science ⚖ 65 KB

As health care costs increase and a growing number of women are without insurance, the one health service that every family needs deserves further attention. Even for the 40% of births covered by Medicaid, safe birthing alternatives that permit a reduction in the $150 billion Medicaid burden would a

Cost-effectiveness of antidepressant med
✍ Thomas W. Croghan; Catherine A. Melfi; William E. Crown; Anita Chawla 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

Background: Antidepressant medications have been shown to effectively relieve symptoms, improve interpersonal and occupational functioning and reduce disability from coexisting medical conditions. Although the newer selective serotonin reuptake inhibitors (SSRIs) have improved tolerability, are easi